Skip to main content
. 2017 Jun 12;8(59):100942–100950. doi: 10.18632/oncotarget.18458

Figure 1.

Figure 1

A. Pre-treatment computed tomography (CT) scan demonstrating ill-defined infiltrative mass measuring 2.7 cm x 5.0 cm. B. CT following 6 doses of FOLFIRINOX chemotherapy showing that the mass involving the head and uncinate process of the pancreas is difficult to define and measure but appears slightly less bulky as compared to the prior examination. C. 6-weeks post-SBRT CT scan reveals interval decrease in infiltrative pancreatic head mass.